The 20 Best Chronic Antibody-Mediated Rejection Doctors near Hackensack, NJ

Samuel Sultan is a Transplant Surgeon in Hackensack, New Jersey. Dr. Sultan has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Kimura Disease, Kidney Transplant, and Pancreas Transplant.

Josue Alvarez is a Transplant Surgeon in Hackensack, New Jersey. Dr. Alvarez is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Alcoholic Cirrhosis, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant.

Sandip Kapur is a Transplant Surgeon and a General Surgeon in New York, New York. Dr. Kapur is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, Kidney Transplant, and Nephrectomy.

Michael Goldstein is a Transplant Surgeon in Hackensack, New Jersey. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Esophagitis, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Alexey Zendel is a Transplant Surgeon in Hackensack, New Jersey. Dr. Zendel is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Liver Failure, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Dr. Chon is an experienced transplant nephrologist and is board-certified in Internal Medicine and Nephrology. His research interests include ethics in transplantation, BK virus nephropathy, and vaccinations in transplant patients. He has served as Chairman for the American Society of Transplanation (AST) Trainee and Young Faculty Community of Practice. Dr. Chon is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Chronic Antibody-Mediated Rejection, Febrile Neutropenia, Islet Cell Transplantation, and Pancreatectomy.

Bruce Gelb is a Transplant Surgeon and a General Surgeon in New York, New York. Dr. Gelb is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Hepatitis, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Bonnie Lonze is a General Surgeon in New York, New York. Dr. Lonze is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. Her top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Dr. Ratner is Professor of Surgery and Director of Renal and Pancreatic Transplantation at Columbia University. Prior to joining the faculty at Columbia, Dr. Ratner was on the faculty of Johns Hopkins University in Baltimore, and served as the Chief of Solid Organ Transplantation at Thomas Jefferson University in Philadelphia. Dr. Ratner was responsible for dramatic growth of the kidney transplant program at CUIMC. He also established the pancreas transplant program, and the Kidney Autotransplant Program. He introduced robotic surgery to our kidney transplant program. Access to organ transplantation has been Dr. Ratner's major academic interest. Dr. Ratner has been a leading innovator in transplantation for over two decades. In 1993, he performed the world's first dual renal transplant. In 1995 (with Dr. Louis Kavoussi) he performed the first laparoscopic donor nephrectomy, and set the stage for its widespread adoption, which resulted in a profound increase in living donor kidney transplantation. Dr. Ratner has made significant contributions in overcoming immunologic incompatibilities that prohibited transplantation. He devised the plasmapheresis/IVIg protocol for alloantibody desensitization in 1998. In 2001, Dr. Ratner orchestrated the second paired-kidney exchange in the U.S. Subsequently, he arranged the first paired kidney exchanges in both Pennsylvania and New York. More recently Dr. Ratner has been a leading proponent of including compatible donor/recipient pairs in kidney exchanges. And, his more contemporary work has looked at the organizational and regulatory barriers to access to care. All of these strategies have increased organ availability and access to transplantation. Additionally, he has made important contributions to improve living donor safety. For his work, Dr. Ratner has received numerous awards and honors. And, he has been invited to speak and operate at various venues around the world. Dr. Ratner has authored or co-authored over 240 peer-reviewed publications, and has been a federally funded investigator. His publications have been cited over 20,000 times. He served as the Chairman of the Board of Directors of the LiveOnNY (formerly the New York Organ Donor Network), and has served on numerous national committees including the Board of the Organ Procurement and Transplantation Network (OPTN). He recently completed a term as the President of the American Society of Transplant Surgeons, and previously served as that Society's Treasurer.Dr. Ratner originally hails from Brooklyn, NY. He received his undergraduate education at the State University of New York at Buffalo. He received his M.D. from Hahnemann University. His general surgery training was obtained at Long Island Jewish Medical Center. He completed a Fellowship in Transplantation Surgery and Immunology at Washington University. In 2011 Dr. Ratner completed a Master of Public Health with a focus on health care policy, administration and management. Dr. Ratner is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Chylous Ascites, Kidney Transplant, and Pancreas Transplant.

Pedro Sandoval is a General Surgeon and a Transplant Surgeon in New York, New York. Dr. Sandoval is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Chronic Antibody-Mediated Rejection, Chylous Ascites, End-Stage Renal Disease (ESRD), Kidney Transplant, and Simultaneous Pancreas Kidney Transplant. Dr. Sandoval is currently accepting new patients.

Soo Youn Yi, M.D. is a kidney and pancreas surgeon.  She has a particular interest in the ethics of transplant and is on the ASTS ethics committee. Dr. Yi is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. Her top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, Simultaneous Pancreas Kidney Transplant, and Kidney Transplant.

Robert Montgomery is a Transplant Surgeon and a General Surgeon in New York, New York. Dr. Montgomery is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Hepatitis, Chronic Antibody-Mediated Rejection, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Nicholas Morrissey is a General Surgeon and a Vascular Surgeon in New York, New York. Dr. Morrissey is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Gangrene, End-Stage Renal Disease (ESRD), Varicose Veins, Atherectomy, and Angioplasty. Dr. Morrissey is currently accepting new patients.

Joshua I. Weiner, MD, is a board-certified transplant surgeon and transplant immunologist. He has particular interests in multi-visceral transplantation and transplant immunology. Dr. Weiner performs intestinal, kidney, and pancreas transplants and investigates transplant tolerance.Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver. Dr. Weiner is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Gastrointestinal Fistula, Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Kasi Mccune is a General Surgeon in New York, New York. Dr. Mccune is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. Her top areas of expertise are Chronic Antibody-Mediated Rejection, End-Stage Renal Disease (ESRD), Polycystic Kidney Disease, Pancreas Transplant, and Kidney Transplant.

Scott Ames is a Transplant Surgeon and a General Surgeon in New York, New York. Dr. Ames is rated as an Advanced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Intestinal Pseudo-Obstruction, Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.

Craig Sauter is a Hematologist in New York, New York. Dr. Sauter is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are T-Cell Lymphoma, Chronic Graft Versus Host Disease (cGvHD), Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft. Dr. Sauter is currently accepting new patients.

John Renz is a Transplant Surgeon in New York, New York. Dr. Renz is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Liver Cancer, Liver Failure, Fibrolamellar Carcinoma, Liver Transplant, and Pancreas Transplant.

Mark Hardy is a General Surgeon in New York, New York. Dr. Hardy is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Gastrointestinal Perforation, Kidney Transplant, and Islet Cell Transplantation.

Kiumars Ranjbar-Tabar is a General Surgeon in New York, New York. Dr. Ranjbar-Tabar is rated as an Experienced provider by MediFind in the treatment of Chronic Antibody-Mediated Rejection. His top areas of expertise are Chronic Antibody-Mediated Rejection, Liver Failure, End-Stage Renal Disease (ESRD), Kidney Transplant, and Simultaneous Pancreas Kidney Transplant.